• The Use Of Real World Evidence To Support Market Access Of Medical Devices – Implications For The German Setting

    Nov 1, 2015, 00:00

  • Biosimilars- Accessing the Uk Market

    Nov 1, 2015, 00:00

  • Caracterización de Pacientes Con Enfermedad Osteoarticular Desde La Perspectiva Del Aseguramiento en Colombia

    Nov 1, 2015, 00:00

  • Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use- Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)

    Nov 1, 2015, 00:00

  • Meta-Analysis to Support Technology Submissions to Health Technology Assessment Authorities- Criticisms By Nice And Evidence Review Groups in the Uk

    Nov 1, 2015, 00:00

  • A Decision Options Approach to Antibiotic RD Investment

    Nov 1, 2015, 00:00

  • Effectiveness and Safety of New and Traditional Oral Anticoagulants in a Population-Based Cohort of New Users with Atrial Fibrillation

    Nov 1, 2015, 00:00

  • To Study The Clinical Characteristics, Treatment Pattern And Factors Associated With The Total Hospital Cost In Acute Respiratory Distress Syndrome In Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Biossimilars, Are they Really Cost Saving? The Case of Recombinant Human Follicle Stimulating Hormone in Portugal

    Nov 1, 2015, 00:00

  • Prevalence Of Chronic Kidney Disease In India- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Pregabalin In The Treatment of Central Neuropathic Pain

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Umeclidinium/Vilanterol In Symptomatic Copd Spanish Patients

    Nov 1, 2015, 00:00

  • Decrease of Patient Costs in the Netherlands- a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc)

    Nov 1, 2015, 00:00

  • condition Specific Utilities- Impact on Icer in a Markov Model for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life (Hrqol) In Splenectomized Immune Thrombocytopenia (Itp) Patients – A Targeted Literature Review

    Nov 1, 2015, 00:00

  • Comparação De Custos E Efetividade Entre Ml- Flow E Baciloscopia Para Auxílio Diagn”Stico E Tratamento Da Hanseníase

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Model Evaluating Component-Resolved Diagnosis (Crd) Versus Standard Testing Method (Skin Prick Testing (Spt)) In The Diagnosis And Treatment of Allergic Rhinitis In The Netherlands

    Nov 1, 2015, 00:00

  • Reference Pricing For Laboratory Tests In The United States- Impact On Prices And Spending

    Nov 1, 2015, 00:00

  • Newer Antiepileptic Drugs Dispensed By Community Pharmacies- Generic Prescribing and Cost

    Nov 1, 2015, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead to Unintended Harm of Ireland’s Health System?

    Nov 1, 2015, 00:00

  • Health State Utilities Associated With Glucose Monitoring Devices

    Nov 1, 2015, 00:00

  • Insurance Plan Switch Patterns Among Breast Cancer Patients Compared to Non-Cancer Patients

    Nov 1, 2015, 00:00

  • Health Services Utilization By Dengue Patient In Brazil, 2012 – 2013- A Multicenter Study

    Nov 1, 2015, 00:00

  • Reducing The Barriers To Capturing Patient Reported Outcomes In Oncology Studies

    Nov 1, 2015, 00:00

  • Modeling The Burden of Abdominal Aortic Aneurysm (Aaa) In Europe In 2013

    Nov 1, 2015, 00:00

  • Steering vaccines through the uk system - what factors influence the likelihood of positive and negative recommendations?

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Anidulafungin, Micafungin, Caspofungin And Fluconazole In The Treatment Of Candidemia And/Or Invasive Candidiasis In Non-Neutropenic Adult Patients In Spain

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of A Genomic Test Compared To Standard Of Care In Breast Cancer Patients In France

    Nov 1, 2015, 00:00

  • Mental Health Disorder Prevalence Trends In Germany- A Longitudinal Analysis

    Nov 1, 2015, 00:00

  • Mortality In A University Pediatric Hospital In Colombia 2000 – 2014

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan

    Nov 1, 2015, 00:00

  • Machine Learning For Identifying Potentially Undiagnosed Post-Stroke Spasticity Patients In United Kingdom

    Nov 1, 2015, 00:00

  • Can Advances in Health Monitors Lead to Health Being Looked at as A Commodity?

    Nov 1, 2015, 00:00

  • French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours- Perspective For Future Trends

    Nov 1, 2015, 00:00

  • The Impact of Societal Views on Market Access- Case Studies For Utilization of Hpv Vaccines in Cervical Cancer and Prep Hiv Preventive Therapy

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer

    Nov 1, 2015, 00:00

  • Using Machine Learning Techniques To Classify Oecd Countries According to Health Expenditures

    Nov 1, 2015, 00:00

  • Cytogenetics And Dopamine Receptor (Drd2) Gene Polymorphism In Schizophrenia Patients

    Nov 1, 2015, 00:00

  • Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile

    Nov 1, 2015, 00:00

  • Psychometric Validation of the Multidimensional Dyspnea Profile (Mdp) Questionnaire

    Nov 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes (Pro) on Market Access Decisions In Markets With Centralized Healthcare Systems

    Nov 1, 2015, 00:00

  • Long-Term Cost-Effectiveness of Transanal Irrigation In Patients With Neurogenic Bowel Dysfunction Who Have Failed Standard Bowel Care

    Nov 1, 2015, 00:00

  • A Retrospective Analysis of Time to Market Access and the Regional Impact of Spanish ‘Place in Therapy’ Reports

    Nov 1, 2015, 00:00

  • Economic Burden Outcomes In Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • Outpatient Utilization and Quality Appraisal of Antibiotics in Turkey

    Nov 1, 2015, 00:00

  • Medical Care And Costs of Patients With Systemic Lupus Erythematosus In Taiwan

    Nov 1, 2015, 00:00

  • Resource Utilisation And Costs In Patients With Post-Stroke Spasticity In The United Kingdom

    Nov 1, 2015, 00:00

  • Associated Factors The Virologic Success In A Group of Patients With Human Immunodeficiency Virus, Managed By A Care Team Integral, Eps|Sura Medellin 2010-2013

    Nov 1, 2015, 00:00

  • Comparison of Pharmaceutical Pricing and Reimbursement Systems In Turkey And Certain Other Eu Countries

    Nov 1, 2015, 00:00

  • Survival And Cost Among Photodynamic Therapy Patients With Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • Using Financial Incentives to Motivate Stair Use In A Workplace Setting- Results From A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Physicians’ Choice As A Comparator In Clinical Trials- Challenges for Pharmacoeconomic Modelling of Innovative Treatments to Support Health Technology Assessments

    Nov 1, 2015, 00:00

  • Cost Saving Associated With Glucose Meter Accuraccy In Spain

    Nov 1, 2015, 00:00

  • Effects Of Lifestyle Interventions On Body Mass Index In Breast Cancer Patients

    Nov 1, 2015, 00:00

  • Innovation Ranking in France and Italy- Differences and their Impact on Pricing and Reimbursement Processes

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Geriatric Diabetics in a Tertiary Care Hospital- A Prospective Study

    Nov 1, 2015, 00:00

  • A Literature Review To Evaluate The Pharmacoeconomic Value Of Ranolazine For The Treatment Of Symptomatic Chronic Stable Angina

    Nov 1, 2015, 00:00

  • Medication Adherance and Satisfaction With Treatment In Patients With Diabetes Mellitus Receiving Oral Combination Therapy- Data of A Real-World Study

    Nov 1, 2015, 00:00

  • Trends In Self-Rated Health Status Among Adults In Greece (2002-2015)

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting

    Nov 1, 2015, 00:00

  • Critical Analysis of Pricing and Reimbursement Process on The Basis of New Indroduced Pharmacoeconomic Guidelines In Bulgaria

    Nov 1, 2015, 00:00

  • Implante de Ahmed Versus Implante de Baerveldt- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service

    Nov 1, 2015, 00:00

  • New Copd Medicinal Products Entrance Analysis And Their Influence On The Number And Cost Of Hospitalizatons Due To Copd Exacerbations

    Nov 1, 2015, 00:00

  • Rapid Increase of Health Litigation As A Means of Market Access For Innovative Medicines In Colombia And The Potential Role Of Health Technology Assessment

    Nov 1, 2015, 00:00

  • Patient Utility Estimates In Patients At High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • Risk Of Pneumonia Associated With The Use Of Ics/Laba- A Retrospective Cohort Study In Korea

    Nov 1, 2015, 00:00

  • The Research on The Relationship Between The Ovarian Function Damage With Fluorosis and The Protective Effect of Selenium

    Nov 1, 2015, 00:00

  • The Devil Is Not So Black As He Is Painted – The Future of Immunization In Poland

    Nov 1, 2015, 00:00

  • Evolution Of Tiotropium Efficacy Vs. Placebo Over Time For The Maintenance Therapy Of Chronic Obstructive Pulmonary Disease- From Investigational Product To Active Reference

    Nov 1, 2015, 00:00

  • Cost-Minimisation Analysis of Dexmedetomidine Versus Propofol in Mechanical Ventilated Patients at Icu

    Nov 1, 2015, 00:00

  • A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Bariatric Surgery In Germany

    Nov 1, 2015, 00:00

  • The Economic Burden Of Cardiac Complications Of Percutaneous Coronary Intervention In England- An Analysis Of Hospital Episode Statistics

    Nov 1, 2015, 00:00

  • Trends in Hospital Standardized Mortality Ratios in Japan

    Nov 1, 2015, 00:00

  • Economic Evaluation For The Rapid Test Dpp® Hiv-Syphilis Assay With Immunochromatography In Pregnant Women In Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients- Decision Analysis

    Nov 1, 2015, 00:00

  • Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Respiratory Medication Therapy Adherence Clinic (Rmtac) On Asthma Patients In Malaysia

    Nov 1, 2015, 00:00

  • Indirect Comparison to Evaluate the Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors (DPP4I) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2I) Added to Insulin Therapy in Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Patient Diagnostic Therapeutic Pathway For Patients With Psoriasis The Organisational Analysis of 13 Excellence Centres Of The Tuscany Region (Italy)

    Nov 1, 2015, 00:00

  • Assesing The Net Fiscal Consequences Of Tobacco Use In A High Consumption And High Tobacco Tax Country- The Case Of Greece

    Nov 1, 2015, 00:00

  • Development Of Medical And Technological Documents On Standardization Of Medical Care In Cardiovascular Diseases In Ukraine

    Nov 1, 2015, 00:00

  • Representing the Threshold in the Cost-Effectiveness Plane- Proposing a New Graphical Convention

    Nov 1, 2015, 00:00

  • Direct Costs And Healthcare Resource Use Associated With Advanced Melanoma In Portugal

    Nov 1, 2015, 00:00

  • Costs of Relapse of Schizophrenia for Colombian Health System

    Nov 1, 2015, 00:00

  • Cost Benefits Of Incorporating Levosimendan Into Cardiac Surgery Practi German Base Case

    Nov 1, 2015, 00:00

  • Tratamiento Ambulatorio Versus Hospitalario Relacionado A Agudizaciones En Pacientes Con Asma Desde Una Perspectiva Institucional Publica Mexicana

    Nov 1, 2015, 00:00

  • Early Benefit Assessment And Uptake Of Pharmaceutical Innovations – Experiences From Germany 2011 To 2014

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

    Nov 1, 2015, 00:00

  • Healthcare Pathways And Burden of Disease of Patients With Inflammatory Bowel Diseases (Ibd)

    Nov 1, 2015, 00:00

  • Antipsychotic Exposure And Risk of Stroke- A Systematic Review And Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • A Streamlined Approach to Ethics Review in Brazil

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

    Nov 1, 2015, 00:00

  • Accessing The Medical Devices Market In Egypt And Saudi Arabia- A Systematic Review Of Policies And Regulations

    Nov 1, 2015, 00:00

  • An Evaluation of a New Regional Decision making Process in Sweden for High-Cost Hospital Therapies

    Nov 1, 2015, 00:00

  • Availability Of Drugs Recommended By Global Initiative For Chronic Obstructive Lung Disease (Gold) For Ukrainian Patients With Copd

    Nov 1, 2015, 00:00

  • The Association Between Tolerability Issues and Health Outcomes Among Patients with Hcv in Brazil

    Nov 1, 2015, 00:00

  • Using Real-World Hospital Purchasing And Consumption Data To Improve Healthcare Systems Efficiencies

    Nov 1, 2015, 00:00

  • A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

    Nov 1, 2015, 00:00

  • Character of Toxic Damage of Liver In Influences of Substances of Mediator to Fetal Cells on Hepatocytes In Acute Liver Failure

    Nov 1, 2015, 00:00

  • Burden Of Symptomatic Copd Patients In Spain- Data From Continuing To Confront Copd International Patient Survey 2012-2013

    Nov 1, 2015, 00:00

  • Lipid Modifying Therapy Treatment Patterns And Cholesterol Control After Cardiovascular Events In The United Kingdom

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Chemotherapy Regimen In Metastatic Breast Cancer Egyption Prospective

    Nov 1, 2015, 00:00

  • Access To The Procedure Care of Colorectal Cancer In Brazilian Public Health System- Use Of Diagnosis Resources In São Paulo State

    Nov 1, 2015, 00:00

  • Delay Of Optimal Nocturia Treatment Is Costly- Results Of A Real World Survey Of Patients In Europe And The Usa

    Nov 1, 2015, 00:00

  • Proton Pump Inhibitors In Italy- It’s Time to Make A (Policy) Change

    Nov 1, 2015, 00:00

  • Aumento del Riesgo de Cancer por Efecto de Variaciones Acumuladas en la Exposici”n a la Radiacion en Estudios de Radiología Convencional y Tomografía Computarizada en Pacientes Pediátricos

    Nov 1, 2015, 00:00

  • Interpreting Results from Bayesian Network Meta-Analyses (Nma)- A Guide for Non-Statisticians

    Nov 1, 2015, 00:00

  • Role Of Budget Impact Analysis In Market Access Of Biosimilars

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Bladder Cancer- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Benefit-Risk of Vka for Atrial Fibrillation Before Doac- a Cohort Study in a Claims and Hospitalization Database

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Ultra-Orphan Therapies

    Nov 1, 2015, 00:00

  • Safety And Insurance Premium Implications For Hospitals Based On Subcutaneous Versus Intravenous Administration Of Oncology / Hematology Therapies- Case Studies With Rituximab (Mabthera) And Trastuzumab (Herceptin)

    Nov 1, 2015, 00:00

  • Ankylosing Spondylitis Treatment and Follow-Up Costs in Colombia

    Nov 1, 2015, 00:00

  • How Has The Smc Patient And Clinician Engagement (Pace) Process Been Used In Assessments Of End-Of-Life Medicines And Medicines To Treat Very Rare Conditions?

    Nov 1, 2015, 00:00

  • Persistence to Therapy and the Associated Risk of Fractures with Antiosteoporotic Drugs

    Nov 1, 2015, 00:00

  • Systematic Review And Meta-Analysis of Efficacy And Safety of Simeprevir And Sofosbuvir For Hcv Genotype 1 Infection

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Rivaroxabán Como Profilaxis En Cirugía De Reemplazo Total De Cadera Y/O De Rodilla Frente A Enoxaparina, En Colombia

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Patients’ Perception of Adherence to Therapy In Ulcerative Colitis- Results of A Survey to Specialized Centers

    Nov 1, 2015, 00:00

  • A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis- Compliant Vs. Non-Compliant Patients

    Nov 1, 2015, 00:00

  • Decision Drivers in Health Technology Assessment in Hepatitis C

    Nov 1, 2015, 00:00

  • Evaluation Analysis of Smoking Population in Ulaanbaatar

    Nov 1, 2015, 00:00

  • Prostatectomy- a Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques

    Nov 1, 2015, 00:00

  • Search for Clinically and Economically Effective Lymphomas Treatment

    Nov 1, 2015, 00:00

  • Cost utility analysis of spinal cord stimulation vs. Reoperation in the treatment of failed back surgery syndrome in colombia

    Nov 1, 2015, 00:00

  • Cost of Illness (Out of Pocket Costs Paid By Patient) for T.B in Quetta City, Pakistan

    Nov 1, 2015, 00:00

  • Do Payers Equally Value the Cost Per Month of Overall Survival for Metastatic Castration Resistant Prostate Cancer within the Eu5?

    Nov 1, 2015, 00:00

  • Analysis of The Cost of Invasive Fungal Infections In Patients With Hemopoetic Stem Cell Transplantation

    Nov 1, 2015, 00:00

  • Comparison of Cost of Treatment of Selected Cancers with Patented Drugs- India Versus its Neighbors

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

    Nov 1, 2015, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary In Case Of Erythropoietin Products

    Nov 1, 2015, 00:00

  • Medical Devices For Bandaging And Plasters. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Cetuximab In First-Line Treatment Of Patients With Metastatic Colorectal Cancer In Belgium And The Netherlands

    Nov 1, 2015, 00:00

  • Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Utilidad Del Uso De Cetuximab Como Última Línea De Tratamiento Del Cáncer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • Sq® Hdm Slit-Tablets In Addition To Pharmacotherapy Are Cost-Effective Compared To Pharmacotherapy Only In Treating Patients With Allergic Asthma

    Nov 1, 2015, 00:00

  • Risk Factors and Causes of Intrauterine Death

    Nov 1, 2015, 00:00

  • Healthcare Costs In Psoriatic Arthritis Patients Newly Initiated on Apremilast or Biologic Therapies

    Nov 1, 2015, 00:00

  • Comparative Efficacy And Costs Of Treatment Sequences In Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Tioropium+Olodaterol Respimat; Budget Impact In The Uk

    Nov 1, 2015, 00:00

  • Inflation, Inflexibility and Irrelevance – the Need for Inflation to be Accounted for in Icer Thresholds

    Nov 1, 2015, 00:00

  • Estimation of The Relative Efficacy of Licensed Regimens for Genotype-1 Hcv Infection Using A Mixed Treatment Comparison

    Nov 1, 2015, 00:00

  • Relationship Between Non Compliance to Claim Medication in Pharmacy and Incidence of Hospitalizations in Patients with Breast Cancer

    Nov 1, 2015, 00:00

  • The Impact of Anti-Tnf (Etanercept) Therapy on Work Productivity in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in the Czech Republic

    Nov 1, 2015, 00:00

  • Regulations of The German Drug Market

    Nov 1, 2015, 00:00

  • Quality of Life Issues Important to Patients with Haematological Malignancies

    Nov 1, 2015, 00:00

  • Longitudinal Changes in Medical Services Costs from 2006 to 2012 for Newly Diagnosed T2D Patients

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated With Non-Valvular Atrial Fibrillation In Italy

    Nov 1, 2015, 00:00

  • Cost Implications of Further Limiting or Increasing Generic Prescribing of Antiepileptics In English And Welsh General Practices

    Nov 1, 2015, 00:00

  • National Study to Assess The Costs of Patients With High Myopia With and Without Choroidal Neovascularisation

    Nov 1, 2015, 00:00

  • Usability Testing of an Integrated Glucometer and Handheld Electronic Patient-Reported Outcome System

    Nov 1, 2015, 00:00

  • The Most Profitable Health Insurance “Company” In Turkey

    Nov 1, 2015, 00:00

  • Cost-Utility Of Ranolazine For The Symptomatic Treatment Of Patients With Chronic Angina Pectoris In Greece

    Nov 1, 2015, 00:00

  • Opportunistic Screening For Atrial Fibrillation In Primary Care – A Clinical And Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Preference Elicitation On Benefits And Risks Of Medicines Using A Discrete Choice Experiment

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 4 Pro Questionnaires for Uterine Fibroids

    Nov 1, 2015, 00:00

  • Baseline Characteristics of Rheumatoid Arthritis Patients Starting Certolizumab Pegol Therapy And Glucocorticoid Prescription In The Eclair Study In 2012–2013

    Nov 1, 2015, 00:00

  • Conditional Agreements For Innovative Therapies In Italy- The Case Of Pirfenidone

    Nov 1, 2015, 00:00

  • Resource Utilization And Treatment Costs Of Stroke In Patients With Non-Valvular Atrial Fibrillation In Spain

    Nov 1, 2015, 00:00

  • Access to Biologics for Rheumatoid Arthritis in the Public Sector of a Latam Country

    Nov 1, 2015, 00:00

  • Utilizacion De Antibacterianos De Uso Restringido En Pacientes Adultos Hospitalizados En El Hospital Las Higueras - Talcahuano

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis Of Nab-Paclitaxel (Abraxane) Plus Gemcitabine In Metastatic Pancreatic Cancer In Slovak Republic

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson’S Disease

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18 Month Booster Dose of A Pertussis-Containing Vaccine on The Australian National Immunisation Program- A Dynamic Model-Based Analysis

    Nov 1, 2015, 00:00

  • Cost-Utility of Bariatric Surgery In Belgium, Denmark, and Italy

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Phid-Cv Routine Vaccination Programme Compared To Pcv-13 In Portugal

    Nov 1, 2015, 00:00

  • Efeitos da Atenção Farmacêutica nos Resultados em Saúde Dos Pacientes- Revisão Sistemática Com Meta-Análises

    Nov 1, 2015, 00:00

  • The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey- an Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de Un Paquete de Tres Torundas de Algodón Estériles Frente a Toallas Impregnadas Con Solución Antiséptica Como Estrategia de Antisepsia en Venopunción

    Nov 1, 2015, 00:00

  • The Budget Impact of Denosumab in the Treatment of Giant Cell Tumor of the Bone (Gctb) in Belgium

    Nov 1, 2015, 00:00

  • Analysis Of In-Hospital Resource Use After An Ischemic Stroke

    Nov 1, 2015, 00:00

  • Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers- Patterns of Treatment and Costs

    Nov 1, 2015, 00:00

  • Cost Analysis of Proton Pump Inhibitors In The Treatment of Gastroesophageal Reflux Disease In Ukraine

    Nov 1, 2015, 00:00

  • Value Judgment of Health Interventions From Different Perspectives- Arguments and Criteria

    Nov 1, 2015, 00:00

  • High Therapeutic Efficiency With Ledipasvir/Sofosbuvir For The Treatment Of Genotype 1 Chronic Hepatitis C In Portugal

    Nov 1, 2015, 00:00

  • Productivity Loss Costs Attributable to Obesity in Working Patients with Diabetes in the US

    Nov 1, 2015, 00:00

  • Economic Impact of Expanded Use of Biologic Therapy for Crohn’s Disease In Latin American Countries

    Nov 1, 2015, 00:00

  • Exenatide Once Weekly Plus Metformin for the Treatment of Type 2 Diabetes Mellitus- A Network Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00

  • The Conceptual Framework and Content Validity of the Polycystic Ovary Syndrome Patient Reported Outcome (Pcos-Pro) Scale

    Nov 1, 2015, 00:00

  • Characterization of Osteoporosis In Portugal - Treatment Patterns And Reasons for Under-Treatment and Non-Persistence With Pharmacological Treatments

    Nov 1, 2015, 00:00

  • Impact of Hta – an Irish Case Study

    Nov 1, 2015, 00:00

  • Campañas de Medicamentos; Instrumento Publicitario Que Atenta Contra Los Genéricos y el Acceso a Medicamentos

    Nov 1, 2015, 00:00

  • Prevalence of Self-Medication and Its Reason Among Pharmacy Students in India- A cross-sectional study

    Nov 1, 2015, 00:00

  • Does Out-Patient Medical Insurance Policy Work Among Ckd Patients In Non-Dialysis Phases? Evidence From Two Sample Cities In China

    Nov 1, 2015, 00:00

  • Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)

    Nov 1, 2015, 00:00

  • Challenges and Benefits of Conducting Value of Information Analysis from the Perspective of Industry- A Simulation Study

    Nov 1, 2015, 00:00

  • The End of the Exceptional Financing of Erythropoiesis-Stimulating Agents in French Hospitals- What are the Impacts For Public Hospitals of Paris ?

    Nov 1, 2015, 00:00

  • Systematic Review Of Productivity Losses Associated With Cardiovascular Disease In Europe

    Nov 1, 2015, 00:00

  • Economic and Humanistic Burden of Ductal Carcinoma in Situ

    Nov 1, 2015, 00:00

  • Skin Whitening Multiple Emulsions Loaded with Green Tea and Lotus Extracts- an Efficacy Study

    Nov 1, 2015, 00:00

  • Differences And Similarities In Hta- A Comparative Analysis Of The Decision-Making Processes For Cancer Drugs Across 4 Countries

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Determinant Factors of the Administrative Pathway to Access Medicines in the Brazilian Health System

    Nov 1, 2015, 00:00

  • Economic Sanctions And Market Access for Pharmaceuticals- Case Studies With Russia, Cuba And Iran

    Nov 1, 2015, 00:00

  • Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld

    Nov 1, 2015, 00:00

  • Societal and Non-Healthcare Costs Associated With Atypical Haemolytic Uraemic Syndrome In The Uk- Results of A Patient Survey

    Nov 1, 2015, 00:00

  • Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Bra A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies

    Nov 1, 2015, 00:00

  • Development of Ms Budget Manager- A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

    Nov 1, 2015, 00:00

  • Finding The Optimal Screening Program For Unknown Atrial Fibrillation Using Simulation Models

    Nov 1, 2015, 00:00

  • Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events- a Large United States Real World Study

    Nov 1, 2015, 00:00

  • There Is Evidence of Increased Risk of Cancer In Patients Using Human Insulin Analogue Glargine For Treatment of Diabetes Mellitus - Overview Based Evaluation

    Nov 1, 2015, 00:00

  • Exploring Variation in Cost-Effectiveness Estimates in Studies that Evaluate Adult Pneumococcal Vaccination in Latin America

    Nov 1, 2015, 00:00

  • National Estimates of Prevalence and Patterns of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson’s Disease in Nursing Home and Home Healthcare Settings in the United States

    Nov 1, 2015, 00:00

  • The Analysis of Telemedicine Technologies In Pediatric Patients

    Nov 1, 2015, 00:00

  • Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective

    Nov 1, 2015, 00:00

  • Characteristics and Outcomes of Patients with Dengue Viral Infection During The Hospitalization At Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Review Of The Current Status Of Ras Mutation Testing In Patients With Metastatic Colorectal Cancer (Mcrc)- Flash-Ras Study

    Nov 1, 2015, 00:00

  • The Impact Of Pharmaceutical Innovation On Longevity In Portugal, 2002–2010

    Nov 1, 2015, 00:00

  • Patients Experience At Hospital Discharge and Readmissions

    Nov 1, 2015, 00:00

  • Leptospirosis; A Zoonotic, Morbid and Fatal Disease- A Record Viewing Study

    Nov 1, 2015, 00:00

  • Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model

    Nov 1, 2015, 00:00

  • Barriers To Participation In Trials Of Cancer- A Survey On Clinical Research Perception

    Nov 1, 2015, 00:00

  • Are Qalys An Appropriate Measure To Use When Evaluating Public Health Interventions In The Uk?

    Nov 1, 2015, 00:00

  • The Role of Education In The Management of Type 1 Diabetes Mellitus In England

    Nov 1, 2015, 00:00

  • Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain- A Delphi Study

    Nov 1, 2015, 00:00

  • Prices of Pharmaceuticals Under a Generic Price Linkage System And a Reference Price System- Comparison of Austria and Finland

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Cardio-Desfibrilador Implantable Comparado Con La Terapia Farmacológica Optima Para El Tratamiento De Los Pacientes Con Falla Cardiaca En Colombia

    Nov 1, 2015, 00:00

  • Cost Comparison of Oral Versus iv Vinorlbine in France in Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Management Of Sore Throat In Community Pharmacy In Fran A National Observational Study

    Nov 1, 2015, 00:00

  • Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure- 1 Year Follow-Up from the Brazilian Public Healthcare System Database

    Nov 1, 2015, 00:00

  • Practices of Substance Abuse and Risky Sexual Behavior Among Adama Science and Technology University Undergraduate Students in 2012/13 Academic Years

    Nov 1, 2015, 00:00

  • The Effect of Positioning The Lower Extremities on Postoperative Bleeding After Total Knee Replacement

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China

    Nov 1, 2015, 00:00

  • First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d

    Nov 1, 2015, 00:00

  • International Differences in the Role of Payer and Administrative Controls in Prescribing Decisions

    Nov 1, 2015, 00:00

  • A Pitcure of Private Health Insurance Policyholders in Italy

    Nov 1, 2015, 00:00

  • Estimating Lifetime Medical Costs From Censored Claims Data

    Nov 1, 2015, 00:00

  • The Rheumatologist’s Perspective In Diagnostic Course and Management of Familial Mediterranean Fever

    Nov 1, 2015, 00:00

  • The Use of Real World Data to Build Economic Models- A Case Study of Osteoporosis

    Nov 1, 2015, 00:00

  • Contraception Patterns In Fran A Real-World Database Analysis

    Nov 1, 2015, 00:00

  • Patient Reported Outcomes in the Development of new Medications for Type 2 Diabetes- a Review of Recently Approved Products

    Nov 1, 2015, 00:00

  • An Analysis Of Drivers Of Positive And Negative Appraisals By Nice’s Medical Technology Evaluation Programme (Mtep)

    Nov 1, 2015, 00:00

  • Association Between Depression And Discontinuation With Antidiabetic Drugs

    Nov 1, 2015, 00:00

  • Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level

    Nov 1, 2015, 00:00

  • Development of A Precis-2 Scoring Grid- How Pragmatic are Pragmatic Trials of Surgical and Pharmaceutical Interventions?

    Nov 1, 2015, 00:00

  • Evaluación Económica Del Uso De Trastuzumab-Emtansine Para El Manejo De Pacientes Con Cáncer De Mama Her2 Positivo Avanzado Con Tratamiento Previo Con Trastuzumab Y Un Taxano Por Separado O En Combinación, Para Venezuela

    Nov 1, 2015, 00:00

  • Uso de recursos y costos relacionados al tratamiento de complicaciones de la diabetes mellitus tipo 2 (dmt2) en colombia. Una estimacion basada en guias de practica clinica (gpc)

    Nov 1, 2015, 00:00

  • Association between Weight Change, Diabetes-Related Healthcare Costs, and HbA1c among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Pattern And Factors Associated With Readmission In Patients Hospitalized For Chronic Obstructive Pulmonary Disease In Taiwan

    Nov 1, 2015, 00:00

  • Análisis Del Comportamiento De La Drepanocitosis En Colombia, Desde La Perspectiva Del Uso De Servicios De Salud

    Nov 1, 2015, 00:00

  • Cost and Cost-Effectiveness Data on Pancreatic Cancer- a Comprehensive Review of the Literature

    Nov 1, 2015, 00:00

  • Patient Reported Outcome in Health Services Research- A Prospective Study of Orthopedic Surgery in Routine Care in Switzerland

    Nov 1, 2015, 00:00

  • Uptake Of Filgrastim ‘Biosimilars’ In The United States- Analysis Of A Medical Transcription Database Of Patient Office Visits

    Nov 1, 2015, 00:00

  • Streamlining The Access Decision Process For German Patients to Receive Reimbursed Treatments In Another European Union Member State

    Nov 1, 2015, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates for Chronic Hcv Gt1 Drugs in Poland

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey- An Expert Panel Approach For Estimation of Costs

    Nov 1, 2015, 00:00

  • Examination of Water Consumption- Knowledge About Water Consumption In Population of Bátya And Pécs

    Nov 1, 2015, 00:00

  • Work Capacity And Health Status Test of Police Officers

    Nov 1, 2015, 00:00

  • Implant Versus Oral Contraception Use- 3-Years Budget Impact Analysis for the National Heal System in Portugal

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Kidney Cancer In Slovakia

    Nov 1, 2015, 00:00

  • Assessment of Hiv-Related Quality of Life in a Representative Sample Of French Patients using Multivariate Multi-Block Statistical Models

    Nov 1, 2015, 00:00

  • The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada

    Nov 1, 2015, 00:00

  • Conflicts’ Mediation Between Consumers and Health Plans- The Usage Profile of The Available Channels for Complaints

    Nov 1, 2015, 00:00

  • Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management

    Nov 1, 2015, 00:00

  • Pharmacoeconomical Characteristics of Different Strategies of Hemostasis During Extensive Hepatectomy

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Long-Acting Insulin Analogues in the Perspective of Brazilian Public Health System

    Nov 1, 2015, 00:00

  • Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Impact Of Percutaneous Coronary Interventions On The Hospitalization Cost, Length Of Stay And Mortality Of Patients Hospitalized With Acute Coronary Syndromes

    Nov 1, 2015, 00:00

  • Economic Evaluations of Treatments for Inflammatory Bowel Diseases

    Nov 1, 2015, 00:00

  • Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China

    Nov 1, 2015, 00:00

  • Indirect Treatment Comparison (Itc) To Demonstrate The Utility Of Oncolitbank- An Oncology Literature Registry

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of the Introduction of Routine Varicella Vaccination in Children in the United Kingdom

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Simeprevir Vs. Telaprevir for The Triple Therapy of Hepatitis C In Kazakhstan

    Nov 1, 2015, 00:00

  • Pharmacovigilance in Oncology- Knowledge and Perception on Adverse Events Reporting in Brazil

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Plaque Psoriasis In The Italian Setting

    Nov 1, 2015, 00:00

  • Intra- And Extra-Organizational Factors Affecting Community Pharmacy Performance

    Nov 1, 2015, 00:00

  • Over-Prescription Of Fingolimod In Germany

    Nov 1, 2015, 00:00

  • A Perspective on the use of Health Technology Assessment in Brazil and Mexico

    Nov 1, 2015, 00:00

  • Analysis Of Costs For Diagnosis And Differential Diagnosis Of Patients With Possible Temporomandibular Disorders In Ukrane

    Nov 1, 2015, 00:00

  • Economic Analysis of Outpatient Parenteral Antimicrobial Therapy (Opat)- A Systematic Review

    Nov 1, 2015, 00:00

  • Disease Prevalence and Healthcare Resources Consumption in Patients with Basal Cell Carcinoma in Italian Lhus

    Nov 1, 2015, 00:00

  • Higher Drug Survival Rates in Patients with Psoriasis Utilizing Etanercept Compared to Adalimumab – a Nationwide Population-Based Cohort Study in Sweden

    Nov 1, 2015, 00:00

  • Effect of Educational Intervention on Osteoporosis Knowledge Among University Female Students in Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Quantifying The Impact of Treatment on The Public Health Burden of Adpkd- A Uk Case Study Using The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • Inpatient Burden Among Patients With Cystic Fibrosis Who Are Homozygous for The F508del Mutation

    Nov 1, 2015, 00:00

  • A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos)

    Nov 1, 2015, 00:00

  • Prescription Patterns Of Drugs For Attention-Deficit/Hyperactivity Disorders In Japanese Children And Adolescents

    Nov 1, 2015, 00:00

  • Burden of Disease of Ovarian Cancer in Spain. Ovarcost Study

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference and Microvascular Complications in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • Economic Modelling Studies Published In 2014- Which Disease Areas Have Been The Main Focus Of Clinical Research?

    Nov 1, 2015, 00:00

  • Measurement Of Hope In Patients With Cancer

    Nov 1, 2015, 00:00

  • Drug Pricing Information Management- Development Of A Web Based E-Pricing System

    Nov 1, 2015, 00:00

  • Global Publication Trends in Medical Nutrition Health Economics

    Nov 1, 2015, 00:00

  • Economic Evaluation of Ulipristal Acetate For The Treatment of Patients With Moderate And Severe Symptoms of Uterine Fibroids Before Surgery In Mexico

    Nov 1, 2015, 00:00

  • A Systematic Review Of Markov Models Evaluating Multi-Component Disease Management Programs

    Nov 1, 2015, 00:00

  • Public Health Outcomes of Paediatric Influenza Vaccination With An Intranasal Tetravalent Live Attenuated Vaccine In Belgium Using A Dynamic Transmission Model

    Nov 1, 2015, 00:00

  • Reducing Insulin Syringe Reuse Can Help Lower Cost of Insulin Waste In Brazil

    Nov 1, 2015, 00:00

  • Orphan Drug Regulation In The Usa, European Union, Japan and South Korea- A Comparative Analysis

    Nov 1, 2015, 00:00

  • Impacto Orçamentário Do Everolimo, Sirolimo E Tacrolimo Para Imunossupressão Em Transplantados Cardíacos No Sistema Público De Saúde Do Brasil

    Nov 1, 2015, 00:00

  • Relationship between Spending on Diabetes Drugs and Occurrence of Risks Associated with Type 2 Diabetes in English General Practices

    Nov 1, 2015, 00:00

  • From Phase Ii Studies to Hta Submissions- Optimal Use of Evidence for Informed Decisions

    Nov 1, 2015, 00:00

  • The United States Specialty Pharmacy Payor Landscape

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Wh ...

    Nov 1, 2015, 00:00

  • Risk Factors for Coronary Artery Disease In Patients With Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • A Retrospective, Cross Sectional Study on the Prevalence of Hypertension and Treatment Status in Obese Patients Using a Healthcare Database in Japan

    Nov 1, 2015, 00:00

  • Comparison between HTA Reports in Veneto and Emilia Romagna- Drugs Assessment Decision Criteria and Priorities

    Nov 1, 2015, 00:00

  • The Consequences Of Replacing The Fleischner Guidelines By A Software-Based Volume Doubling Time Technique- An Early-Stage Research

    Nov 1, 2015, 00:00

  • Immunisation in Latin America- Factors Preventing Uptake of Cost-Effective Vaccines

    Nov 1, 2015, 00:00

  • Benefits And Risks of Vildagliptin/Metformin Versus Sulphonylureas/Metformin Combination Therapy In Type 2 Diabetes Mellitus (T2dm) From Patient’s Perspective- Real-World Data

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Nilotinib In Patients With Chronic Myeloid Leukaemia Eligible To Start The Treatment-Free Remission Phase In Italy

    Nov 1, 2015, 00:00

  • The Competition Between Drugstore And Primary Care And Treatment Choice Of Patients In The Context Of Essential Medicine Policy In Rural China

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Gefitinib In The Treatment Of Non-Small Cell Lung Cancer In China

    Nov 1, 2015, 00:00

  • Monitoring Of Critical Laboratory Results To Improve Quality Of Patient Care In A Large Urban Clinic In Uganda

    Nov 1, 2015, 00:00

  • Economic Evaluation for The Decision Making Process of Implementing of Pharmaceutical Care for The Treatment of Hypertension In The Brazilian Health System- Stage I - Direct-Costs Analysis

    Nov 1, 2015, 00:00

  • Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

    Nov 1, 2015, 00:00

  • Statin Use and Risk of New-Onset Type 2 Diabetes Mellitus and Cardiovascular Disease- a Nationwide Population-Based Observational Study Using National Claim Data

    Nov 1, 2015, 00:00

  • Assocations Between Pain Severity and Quality of Life Domains Among Those Diagnosed With Various Pain Types In Europe

    Nov 1, 2015, 00:00

  • Study on Quality of Nursing Care and Assessment of Safety

    Nov 1, 2015, 00:00

  • Building a Bridge Between Clinical Evidence Research and Patient Preference Research

    Nov 1, 2015, 00:00

  • Cost-Effectivness Analysis of Shizophrenia Treatment With Haloperidol , Olanzapine And Risperidone In Bosnia and Hercegovina ,Republic of Srpska By Application of The Markov Model

    Nov 1, 2015, 00:00

  • A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

    Nov 1, 2015, 00:00

  • Qualitative and Quantitative Analysis of The Scottish Medicines Consortium (Smc) Advice

    Nov 1, 2015, 00:00

  • Orphan Drugs Assessment in Germany- A Comparison with Other International HTA Agencies

    Nov 1, 2015, 00:00

  • Burden of Heart Failure In Latin America- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Italian Law 326/2003 for The Reimbursement of Orphan and Life Saving Drugs Awaiting Market Entry- Approvals, Rejections And Methods In Aifa’s Evaluation Process Between January 2013 And May 2015

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • The Challenges of Carrying out an Indirect Comparison with Single-Arm Studies

    Nov 1, 2015, 00:00

  • In Greece, During 2009-2014, Public Pharmaceutical Expenditure Undoubtedly Fell; But On Whose Backs?

    Nov 1, 2015, 00:00

  • The Burden of Obesity in Mexico- Prevalence, Comorbidities, and Associations With Quality of Life, Resource Utilization and Productivity

    Nov 1, 2015, 00:00

  • Targeted Combination Regimes In Oncology Challenges for Pricing and Reimbursment In Switzerland- Analysis of The Implication and Operational Requirement For Implementation of An Indication Code

    Nov 1, 2015, 00:00

  • Purpose, Belief And Rate of Disclosure of Cam Use Among Diabetic Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Evaluation of Average Cost-Effectiveness Ratios of Standards of Care Across Different Indications

    Nov 1, 2015, 00:00

  • The Indirect Costs of Inflammatory Bowel Disease (Crohn’s Disease And Ulcerative Colitis) Associated With Absenteeism In Poland In 2013

    Nov 1, 2015, 00:00

  • Pro Self-Assessment and Patient Retention in Major Depression Studies- Efficiency of a Direct-To-Patient Contact Approach

    Nov 1, 2015, 00:00

  • Medical Cost Associated with Treatment and Follow-Up of Pantients with Head and Neck Cancer

    Nov 1, 2015, 00:00

  • Impact of Alexithymia and Disease Characteristics on Work Productivity and Activity In Psoriasis Patients With Short Disease Duration- Epidepso Multicentre Study

    Nov 1, 2015, 00:00

  • A Pilot Study Measuring Knowledge and Attitudes Towards Diabetes Mellitus In Kedah, Malaysia

    Nov 1, 2015, 00:00

  • Trends In End-Of-Life Appraisals And Recommendations By Nice For Oncology Therapies

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Gefitinib as the First Line Treatment in Patients With Positive Egfr Mutation In Metastatic or Locally Advanced non-Small Cell

    Nov 1, 2015, 00:00

  • Treatment Continuation And Treatment Characteristics Of Four Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres, Olanzapine Pamoate And Haloperidol Decanoate) In The Netherlands

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Tiotropium For Severe Persistent Asthma In Portugal

    Nov 1, 2015, 00:00

  • Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- A German Hospital Perspective

    Nov 1, 2015, 00:00

  • Efficacy-Effectiveness-Gap – Extent, Causes And Implications

    Nov 1, 2015, 00:00

  • Developing A Drug Price Reference Index In The Philippines

    Nov 1, 2015, 00:00

  • Comparative Tolerability of New Antipsychotic Drugs in Schizophrenia- A Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Adjunctive Anti-Epileptic Drug Trials In Patients With Primary Generalized Tonic-Clonic Seizures Illustrates Changes in Standard of Care Over 12-20 Years

    Nov 1, 2015, 00:00

  • Tabagismo Em Universitários- Uma Revisão Sistemática Da Literatura

    Nov 1, 2015, 00:00

  • Opioids Switch In Chronic Pain- Impact Assessment Using Electronic Health Records

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico

    Nov 1, 2015, 00:00

  • Efficacy And Safety Profile Of Combined Targeted Therapy Against Egfr And Vegf In Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Are Medicines Granted with a Conditional Approval by the European Medicines Agency Gaining Positive Assessment by Payers in France, Germany and the United Kingdom?

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Tiotropium Administrated Through The Respimat Inhaler As Add-On Therapy In Patients With Uncontrolled Severe Asthma In Poland

    Nov 1, 2015, 00:00

  • A Discrete Choice Experiment For Engaging Patients In Reimbursement Decision Making- Patient Preferences On Adjuvant Chemotherapy In Breast Cancer

    Nov 1, 2015, 00:00

  • The Influence Of The Revision Of The Medical Fee Schedule On National Hospital Organisation Hospitals In Japan

    Nov 1, 2015, 00:00

  • Cost Analysis of Two Methods for Improving the Quality of Care (Qoc) Scores in Paediatric Hospital Wards During Winter Periods

    Nov 1, 2015, 00:00

  • Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, From The Spanish Nhs Perspective

    Nov 1, 2015, 00:00

  • Patterns Of Medication Use In Chronic Kidney Disease Stage 5d- Emphasis On Medications For The Management Of Ckd-Mbd

    Nov 1, 2015, 00:00

  • Are the Irish Slower than they Think? A Systematic Analysis of all Recent Ncpe Appraisals

    Nov 1, 2015, 00:00

  • Clinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain

    Nov 1, 2015, 00:00

  • How Can Biosimilars Compete with Existing Biologics- update of the Results of a Previous Study

    Nov 1, 2015, 00:00

  • An Update on Healthcare Resource Use and Economic Burden In Alzheimer’s Disease In The United States (Us) From A Medicare Sample Analysis

    Nov 1, 2015, 00:00

  • Total Annual Cost Associated with Best Supportive Care of Patients with Unresectable Advanced Non-Small-Cell Lung Cancer Under Real-World-Conditions in Relation to Results of International Studies

    Nov 1, 2015, 00:00

  • Malaria Diagnosis And Treatment Practice Following Introduction of Rapid Diagnostic Test In Selected Health Posts of Adama Woreda, East Shewa Zone, Oromia Region,Centeral Ethiopia

    Nov 1, 2015, 00:00

  • The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – A Health Technology Assessment

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Incidence Of Deep Venous Thrombosis And Pulmonary Embolism In Patients With Hip Or Knee Replacement Surgery And Of Its Impact On The Average Length Of Stay And Hospitalization Cost

    Nov 1, 2015, 00:00

  • The 3-Arm Strategy for Readmission Prevention- Automated Predictive Modeling, Readmission Prevention Intervention, and Monitoring

    Nov 1, 2015, 00:00

  • Pricing and Reimbursement Policies of Turkey and Ukraine

    Nov 1, 2015, 00:00

  • Costs of Adverse Drug Events- Systematic Review

    Nov 1, 2015, 00:00

  • Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis- A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm)

    Nov 1, 2015, 00:00

  • Cost of Paediatric Vaccine Administration in the United Kingdom (UK)- a Time and Motion (TM) Study

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Trimetazidine In The Management Of Chronic Stable Angina In Greece

    Nov 1, 2015, 00:00

  • Field Monitoring Of The Z Benefits For Breast Cancer Of The Philippine Health Insurance Corporation

    Nov 1, 2015, 00:00

  • Therapy Of Depression In Cancer And Non-Cancer Patients In German Neuropsychiatric Practices

    Nov 1, 2015, 00:00

  • Identification Of Items For A Standardised Resource-Use Measure- Review Of Current Instruments

    Nov 1, 2015, 00:00

  • Treatment Patterns And Budgetary Impact of Chemotherapy Drugs In A Brazilian Private Health Plan (Php)

    Nov 1, 2015, 00:00

  • Custo-Efetividade Da Cintilografia Óssea De Corpo Inteiro Na Avaliação Pre-Transplante Hepático De Pacientes Com Carcinoma Hepatocelular Na Região Sul Do Brasil

    Nov 1, 2015, 00:00

  • A Pragmatic Approach to Data Source Selection for use In Real-World Evidence (Rwe) Generation

    Nov 1, 2015, 00:00

  • A Cost-Effective Enhanced Retrospective Observational Study Methodology to Capture Economic Burden Evidence in a Rare Disease Using Non-Tuberculous Mycobacteria Infection as a Model

    Nov 1, 2015, 00:00

  • Autosomal Polycystic Kidney Disease (Adpkd)- Costs And Resource Utilisation In The Nordic Countries

    Nov 1, 2015, 00:00

  • Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the ...

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Adrenal Insufficiency Receiving Plenadren Compared With Immediate-Release Hydrocortisone

    Nov 1, 2015, 00:00

  • Risk of Fracture in Type 2 Diabetes Mellitus Patients- Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Various Treatment Strategies in Resistant Hypertension

    Nov 1, 2015, 00:00

  • Patient Access Schemes Within The Uk- A Retrospective Analysis

    Nov 1, 2015, 00:00

  • Patient Benefits And Cost Savings Predicted For Mineralocorticoid-Receptor Antagonist Treatment Of Early And Advanced Diabetic Kidney Disease

    Nov 1, 2015, 00:00

  • Bone Pain And Bone Targeting Agent (Bta) Treatment Patterns In Patients With Bone Metastases (Bms) From Breast Cancer (Bc) In Real World Setting In Europe

    Nov 1, 2015, 00:00

  • Aspirin Versus Clopidogrel in Patients with Ischemic Stroke- a Cost and Effectiveness Comparison from Beijing Medical Insurance Database

    Nov 1, 2015, 00:00

  • Anticoagulant Treatment After Vte In The Netherlands

    Nov 1, 2015, 00:00

  • The Economics of the Treatment and Follow-Up of Patients with Glioblastoma

    Nov 1, 2015, 00:00

  • Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease

    Nov 1, 2015, 00:00

  • La Hipoglucemia Incrementa El Gasto En Salud Y Deteriora La Productividad De Pacientes Con Diabetes Tipo 1 Y Tipo 2

    Nov 1, 2015, 00:00

  • Prma Reform in Poland – Impact on Pharmaceutical Industry and Market Access

    Nov 1, 2015, 00:00

  • Selecting Evidence-Based Preventive Treatment Thresholds By Optimizing Preferred Outcomes

    Nov 1, 2015, 00:00

  • Opioid Addiction Treatment in the eu5- Market Access Levers for Emerging Brands Entering a Generic Market

    Nov 1, 2015, 00:00

  • Budget Impact Model for Cervical Cancer Screening Using Hpv Tests In Chile

    Nov 1, 2015, 00:00

  • A Real-World Analysis Of Korean Nation-Wide Database- Pattern, Adherence, And Associated Heatlhcare Costs Of Imatinib Among Patients With Chronic Myeloid Leukemia

    Nov 1, 2015, 00:00

  • Additional Cost of Vte In Patients with Cancer- an Approach Based Databases

    Nov 1, 2015, 00:00

  • Drug Pricing Reform in China - An Analysis of Piloted Pricing Approaches in the Context of International Experience

    Nov 1, 2015, 00:00

  • Effectiveness Of Supporting Informal Caregivers Of People With Dementia- A Systematic Review

    Nov 1, 2015, 00:00

  • Translation and Linguistic Validation of the Caregiver Quality of Life Cystic Fibrosis Scale (Cqolcf) and the Multidimensional Scale of Perceived Social Support (Mspss) for use in Germany and the United Kingdom (Uk)

    Nov 1, 2015, 00:00

  • Prediction Of Future Health Insurance Expenditures In Hungary According To Population Forecast Scenarios

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89 (current)
  • 90
  • »